Tiziana Life Sciences Ltd
NASDAQ:TLSA

Watchlist Manager
Tiziana Life Sciences Ltd Logo
Tiziana Life Sciences Ltd
NASDAQ:TLSA
Watchlist
Price: 1.54 USD 1.32% Market Closed
Market Cap: 171.6m USD

Relative Value

There is not enough data to reliably calculate the relative value of TLSA.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TLSA Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.8
vs History
vs Industry
Median 3Y
-6.5
Median 5Y
-6.5
Industry
24.1
Forward
-11.6
vs History
vs Industry
Median 3Y
-6.6
Median 5Y
-7.5
Industry
21.8
vs History
vs Industry
Median 3Y
-6.5
Median 5Y
-7.4
Industry
23.8
vs History
33
vs Industry
1
Median 3Y
18.6
Median 5Y
5.1
Industry
3.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.3
vs History
vs Industry
Median 3Y
-5.1
Median 5Y
-4
Industry
6.3
vs History
vs Industry
Median 3Y
-5.1
Median 5Y
-4
Industry
6.7
Forward
-5
vs History
vs Industry
Median 3Y
-6.5
Median 5Y
-5.7
Industry
7.9
vs History
vs Industry
Median 3Y
-6.5
Median 5Y
-5.7
Industry
6.3
vs History
41
vs Industry
5
Median 3Y
27.6
Median 5Y
37.3
Industry
5.5

Multiples Across Competitors

TLSA Competitors Multiples
Tiziana Life Sciences Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Tiziana Life Sciences Ltd
NASDAQ:TLSA
183m USD 0 -14.3 -9.6 -9.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 710 712 -160 222 -194 560.6 -192 340.5
US
Abbvie Inc
NYSE:ABBV
402.8B USD 6.8 171.5 16.6 23.5
US
Amgen Inc
NASDAQ:AMGN
178.3B USD 5 25.5 18.3 18.3
US
Gilead Sciences Inc
NASDAQ:GILD
154.2B USD 5.3 19 12.8 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 9.9 31.5 23.1 24.2
US
Epizyme Inc
F:EPE
94.1B EUR 2 089.8 -533.3 -580.7 -565.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.1B USD 5.8 17.9 17.1 19.4
AU
CSL Ltd
ASX:CSL
85.8B AUD 3.7 19 12.8 16
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
54B USD 16.8 1 238.8 162.9 197.5
NL
argenx SE
XBRU:ARGX
44.4B EUR 14.5 34.1 58.8 60.4
P/E Multiple
Earnings Growth PEG
UK
Tiziana Life Sciences Ltd
NASDAQ:TLSA
Average P/E: 194.7
Negative Multiple: -14.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 222 N/A N/A
US
Abbvie Inc
NYSE:ABBV
171.5
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.5
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.5
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -533.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
9%
2
AU
CSL Ltd
ASX:CSL
19
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 238.8
N/A N/A
NL
argenx SE
XBRU:ARGX
34.1
40%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Tiziana Life Sciences Ltd
NASDAQ:TLSA
Average EV/EBITDA: 40.3
Negative Multiple: -9.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 560.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.6
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.3
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.1
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -580.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.1
11%
1.6
AU
CSL Ltd
ASX:CSL
12.8
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
162.9
N/A N/A
NL
argenx SE
XBRU:ARGX
58.8
807%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Tiziana Life Sciences Ltd
NASDAQ:TLSA
Average EV/EBIT: 46.5
Negative Multiple: -9.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 340.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.5
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.3
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.2
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
13%
1.5
AU
CSL Ltd
ASX:CSL
16
11%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
197.5
N/A N/A
NL
argenx SE
XBRU:ARGX
60.4
N/A N/A